Related references
Note: Only part of the references are listed.Delay to Colectomy and Survival for Patients Diagnosed with Colon Cancer
Sanjay P. Bagaria et al.
JOURNAL OF INVESTIGATIVE SURGERY (2019)
Functional interrelationship between TFII-I and E2F transcription factors at specific cell cycle gene loci
Yong Shen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
TAX1BP1 overexpression attenuates cardiac dysfunction and remodeling in STZ-induced diabetic cardiomyopathy in mice by regulating autophagy
Yang Xiao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions
Cristina Barbagallo et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Evaluation of revascularization after total arch replacement in common carotid artery occlusion
Yasuhiro Matsuda et al.
WORLD JOURNAL OF CLINICAL CASES (2018)
Controlling Depth of Cellular Quiescence by an Rb-E2F Network Switch
Jungeun Sarah Kwon et al.
CELL REPORTS (2017)
Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma
Lu Chen et al.
ONCOTARGET (2016)
MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer
GuiFeng Lu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
miR-31 promotes proliferation of colon cancer cells by targeting E2F2
Tong Li et al.
BIOTECHNOLOGY LETTERS (2015)
In Vivo Disruption of an Rb-E2F-Ezh2 Signaling Loop Causes Bladder Cancer
Mirentxu Santos et al.
CANCER RESEARCH (2014)
Functional impact of colorectal cancer-associated mutations in the transcription factor E2F4
Marie-Christine Paquin et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
E2F transcription factors and digestive system malignancies: How much do we know?
Athanasios Xanthoulis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression
Luis A. Carvajal et al.
GENES & DEVELOPMENT (2012)
Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73-and E2F1-mediated expression of PUMA and Siva-1
Ramesh M. Ray et al.
APOPTOSIS (2011)
MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3
Li Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance
Julie Millour et al.
MOLECULAR CANCER THERAPEUTICS (2011)
RB-E2F1 Molecular rheostat for autophagy and apoptosis
Hong Jiang et al.
AUTOPHAGY (2010)
Erratum to: Characterization of Nitrotyrosine-Modified Proteins in Cerebrospinal Fluid
Ashley S. Beasley et al.
Clinical Proteomics (2010)
E2F4 Expression Is Required for Cell Cycle Progression of Normal Intestinal Crypt Cells and Colorectal Cancer Cells
Hugo Garneau et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
E2F2 represses cell cycle regulators to maintain quiescence
Arantza Infante et al.
CELL CYCLE (2008)
E2F2 - a potential new molecular marker for colon carcinogenesis
C. Nicolet et al.
EJC SUPPLEMENTS (2008)
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
Hiroshi Tazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Androgen receptor- and E2F-1-targeted thymoquinone therapy for hormone-refractory prostate cancer
Ahmed O. Kaseb et al.
CANCER RESEARCH (2007)
Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities
E Stead et al.
ONCOGENE (2002)
Sibling rivalry in the E2F family
JM Trimarchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
The Rb/E2F pathway and cancer
JR Nevins
HUMAN MOLECULAR GENETICS (2001)
Share Paper
